Bioiberica receives authorisation for Mobilee® as novel food ingredient in Brazil

The Health Regulatory Agency (ANVISA) of the Brazilian Ministry of Health has provided marketing authorisation for Mobilee^® as a novel food ingredient in the country. Part of Bioiberica’s branded ingredients portfolio for healthcare, Mobilee^® is a patented ingredient derived from rooster comb extract that is rich in hyaluronic acid. Proven to contribute to maintaining joint health and muscular function, Mobilee^® contains a high concentration of hyaluronic acid and other components, including collagen and polysaccharides. Its nutritional characteristics and safety have been tested in six preclinical trials and five randomised clinical trials over the last twelve years. Now available for use in food applications across Brazil, manufacturers across the country are able to meet growing consumer demand for products that support joint health and mobility.

Dr Daniel Martínez, Head of Human Health R&D at Bioiberica, explains: “Mobilee^® is an innovative product that is naturally absorbed by the human body. Thanks to the synergy of its individual components - hyaluronic acid, collagen and polysaccharides - the benefits Mobilee^® can offer, go far beyond the advantages offered by hyaluronic acid alone. Taking just 80 mg per day for at least two months preserves joint health and muscular function.”

Mobilee^® is authorised as an ingredient for food supplements and functional foods by the main competent authorities worldwide. These include the European Union (Novel Food), United States (GRAS status), Canada (medicinal supplement), Australia and New Zealand (medicinal supplement and non-traditional ingredient for use in functional foods), India (functional ingredient) and Indonesia and Taiwan (nutritional supplement).

Jaume Reguant, Director of Healthcare at Bioiberica, adds: “Brazil is a key market for Bioiberica in the area of joint health, where we are already market leader with our native type II collagen, b-2Cool^®, thanks to the strategic partnership with our Brazilian partner, Ayalla. Together with them, we will continue to meet the needs of thousands of people who look to maintain healthy joints.”

Bioiberica is a worldwide leader in the life sciences sector, committed to improving the health and well-being of people, animals and plants. Bioiberica is the leading manufacturer of heparin's pharmaceutical active substance and the world bellwether in the research, production, and sale of other drugs and ingredients like chondroitin sulfate, glucosamine, hyaluronic acid, native type II collagen, and thyroid extracts.